These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7522595)

  • 21. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
    Carlsson L; Abrahamsson T
    Eur J Pharmacol; 1989 Jul; 166(2):157-64. PubMed ID: 2792189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Captopril and ramiprilat protect against free radical injury in isolated working rat hearts.
    Pi XJ; Chen X
    J Mol Cell Cardiol; 1989 Dec; 21(12):1261-71. PubMed ID: 2698963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
    Zhang X; Dunham EW; Zimmerman BG
    J Hypertens; 1995 Dec; 13(12 Pt 1):1413-19. PubMed ID: 8866903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
    Skowasch D; Viktor A; Schneider-Schmitt M; Lüderitz B; Nickenig G; Bauriedel G
    Clin Res Cardiol; 2006 Apr; 95(4):212-6. PubMed ID: 16598590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of captopril on hypoxia-induced proliferation and collagen synthesis in pulmonary vascular smooth muscle cells.
    Shen J; Xu Y
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):349-52. PubMed ID: 10452123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal regulation of cytosolic free calcium in vascular endothelial cells from spontaneously hypertensive rats.
    Wang R; Sauvé R; de Champlain J
    J Hypertens; 1995 Sep; 13(9):993-1001. PubMed ID: 8586835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide release from rat aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitors.
    Ikeda U; Shimada K
    Eur J Pharmacol; 1994 Nov; 269(3):319-23. PubMed ID: 7534708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Converting enzyme inhibitors and brain angiotensin.
    Phillips MI; Kimura B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S82-90. PubMed ID: 2438497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat.
    Richer C; Doussau MP; Giudicelli JF
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):865-72. PubMed ID: 2562138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase C: modulation of vasopressin-induced calcium influx and release in A7r5 vascular smooth muscle cells.
    Kaplan-Albuquerque N; Di Salvo J
    Arch Biochem Biophys; 1998 Nov; 359(2):209-14. PubMed ID: 9808762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Kajiwara Y; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed-type inhibition of pulmonary angiotensin I-converting enzyme by captopril, enalaprilat and ramiprilat.
    Baudin B; Bénéteau-Burnat B
    J Enzyme Inhib; 1999; 14(6):447-56. PubMed ID: 10536878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
    Hecker M; Benzing T; Busse R
    Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
    Hiwada K; Inoue Y; Kokubu T
    Gen Pharmacol; 1990; 21(4):555-8. PubMed ID: 2165961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of angiotensin converting enzyme inhibitors on cardiac noradrenaline release.
    Richardt G; Kranzhöfer R; Schömig A
    Eur Heart J; 1991 Dec; 12 Suppl F():121-3. PubMed ID: 1804631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effects of angiotensin-converting enzyme inhibitors with bradykinin, angiotensin II and their specific antagonists on concanavalin A-induced proliferation of mouse T-lymphocytes.
    Yeung JH
    Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):163-72. PubMed ID: 8046949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498.
    van Gilst WH; de Graeff PA; Wesseling H; de Langen CD
    J Cardiovasc Pharmacol; 1986; 8(4):722-8. PubMed ID: 2427810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of extracellular Mg2+ concentration on agonist-induced cytosolic free Ca2+ transients.
    Zhu Z; Tepel M; Spieker C; Zidek W
    Biochim Biophys Acta; 1995 Feb; 1265(1):89-92. PubMed ID: 7857989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of captopril and enalaprilat on intracellular Ca2+, Na+ contents and pH in hypoxic and reoxygenated cardiomyocytes.
    Wang J; Zhang PJ; Zhang L; Qi JH; Wei PJ; Jin ZJ
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):140-2. PubMed ID: 10072966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.